Credit available: 0.75 of AMA, ANCC, or ACPE
NMSC is increasing in incidence in the United States and globally, but recent advances provide increasingly more opportunities for clinicians to develop treatment plans that take their patients’ unique needs into consideration. Dermatologists and oncologists can work together to provide optimal treatment for patients
This webcast features:
- Embedded access to clinical trial data, mechanism-of-action videos, published studies, and other resources that support the latest clinical data.
- The latest guidelines on identification of NMSC, and new information on current and future advancements in treatment.
- Free AMA, ANCC, and ACPE credit. View the full CME details for more information.
Omid Hamid, MD
Chief of Translational Research/Immuno-Oncology
The Angeles Clinic & Research Institute
Co-Director, Cutaneous Malignancy Program